Clinical Trial Update: Safety Evaluation of Seraph® 100 to Reduce Bacteremia in Patients on Hemodialysis [NA]

View source ↗

Summary

Clinical trial update reporting safety evaluation of Seraph® 100 for reducing bacteremia in patients on hemodialysis; completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacteremia
• Bacterial Infection

Drugs mentioned

• Seraph 100

Snippet

Sponsor: ExThera Medical Corporation | Conditions: Bacteremia, Bacterial Infection | NA | Status: COMPLETED | Results posted: 2019-08-12